NeoGenomics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
NEO Key Statistics
Stock Snapshot
With a market cap of 1.1B, NeoGenomics(NEO) trades at $8.48. The stock has a price-to-earnings ratio of -11.32.
On 2026-05-13, NeoGenomics(NEO) stock traded between a low of $8.45 and a high of $8.82. Shares are currently priced at $8.48, which is +0.4% above the low and -3.9% below the high.
The NeoGenomics(NEO)'s current trading volume is 153.75K, compared to an average daily volume of 2.8M.
During the past year, NeoGenomics(NEO) stock moved between $4.72 at its lowest and $13.74 at its peak.
During the past year, NeoGenomics(NEO) stock moved between $4.72 at its lowest and $13.74 at its peak.
NEO News
In late April 2026, NeoGenomics, Inc. raised its full‑year 2026 revenue guidance to US$797.0 million–US$803.0 million and reported first‑quarter sales of US$186...
Analyst ratings
67%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.